Preparation of bovine platelet aggregating factor (PAF)

An extract of rat submandibular glands activates platelets and enhances cutaneous vascular permeability in rats and guinea pigs

Washed, [3H]serotonin-labeled platelets from rats and guinea pigs were stimulated in vitro with a novel protein extracted from rat submandibular salivary glands (RS-PAP) and with the phospholipid platelet- activating factor 1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). Rat platelets, which are refractory to AGEPC stimulation, underwent shape-change, aggregation and secretion of [3H]serotonin in response to graded doses of RS-PAP and AGEPC. Intradermal injections of histamine, RS-PAP and AGEPC caused a dose-related increase in local microvascular permeability in rats, as measured by the extravasation of plasma containing Evans blue dye. Similarly, histamine, RS-PAP and AGEPC increased cutaneous vascular permeability when injected intradermally in guinea pigs. The vascular permeability induced by histamine and RS-PAP, but not by AGEPC, was partially inhibited by pretreatment with an antihistamine (diphenhydramine HCl). Pretreatment of guinea pigs with captopril, an inhibitor of angiotensin-converting enzyme (ACE), partially inhibited cutaneous responses to subsequent intradermal injections of histamine, RS-PAP and AGEPC. Regardless of pretreatment with diphenhydramine or captopril, skin test sites injected with large amounts of RS-PAP became hemorrhagic within minutes and necrotic within 12 hours.

Parallel characterization of bovine von Willebrand protein (factor VIII-associated protein) by light scattering and SDS gel electrophoresis

Highly purified bovine von Willebrand protein (vWP) has been studied with two complementary techniques. Light scattering measurements on different samples give weight average molecular weights in the range from 7 to 13 million, radius of gyration between 75 and 140 nm and diffusion coefficient near 4.15 X 10(-8) cm2/sec. Scans after electrophoresis in sodium dodecyl sulfate on 2% agarose gels, stained with Coomassie blue, allow calculation of a mass distribution over a series of oligomers with relative size in a range from 1 to 20. The ratio of the average mol. wt. from light scattering and the average size for the observed distribution, which is the mol. wt. increment for successive vWP oligomers, has been determined and found to be 1.0 million. This implies that the molecules of vWP are oligomers of subunits themselves consisting of 4 polypeptide chains each of mol. wt. circa 250,000.

A novel platelet-activating protein derived from rat submandibular glands

Among the various naturally occurring substances which induce platelet aggregation and secretion, considerable attention has been focused recently on the phospholipid platelet-activating factor (PAF) derived from a variety of mammalian cells. In this report, we describe a platelet-activating protein, designated RS-PAP, which was isolated and partially purified from the submandibular salivary glands of adult male rats. This material caused a dose-related in vitro activation of washed, [3H]serotonin-labeled platelets from rats, rabbits and humans. The biologic activity of RS-PAP was compared with that of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC), a well-characterized representative of the phospholipid platelet-activating factors, and collagen, a potent platelet-stimulating protein. The activation of washed rabbit platelets by RS-PAP required extracellular calcium for both aggregation and secretion of [3H]serotonin, and was not inhibited by indomethacin. Furthermore, RS-PAP was not inhibited by pretreatment with phenylmethylsulfonyl fluoride, iodoacetate, hirudin or an acetylhydrolase which specifically degrades the phospholipid AGEPC. RS-PAP was completely inactivated by heating at 56 degrees C for 20 minutes, by trypsinization and by a phospholipid extraction procedure. Gel filtration on Sephacryl S-200 indicated an approximate molecular weight of 22,000 - 25,000 daltons. Thus RS-PAP appears to be a new platelet-stimulating protein which activates a variety of mammalian platelets.

A light-scattering study of bovine factor VIII

Classical light-scattering measurements made on bovine Factor VIII preparations, which contain a series of multimers ranging from 1 greater than 12 X 10(6) molecular weight, gave a weight average molecular weight of about 8 X 10(6) and a z-average radius of gyration of about 3000 A. Characteristic dimensions for variously shaped models were calculated.

The calcium-dependent neutral protease of human blood platelets: a comparison of its effects on the receptors for von Willebrand factor and for the Fc-fragment derived from IgG

Glycocalicin (Gc) is the large, water soluble fragment, obtained by cleavage of one of the major membrane glycoproteins, GP Ib, of human platelets by means of the endogenous, calcium-dependent neutral protease (CNP) obtained from lysed platelets. GP Ib has been proposed as the receptor for von Willebrand factor (vWF) as well as for the Fc-receptor of the platelet surface. We have investigated, whether Gc was involved in a receptor function for aggregated human IgG, which is a powerful activator of platelets. Neither Gc nor asialo-Gc inhibited the stimulation of human blood platelets by bisdiazoniumbenzidine-aggregated human IgG (BDB-IgG). Moreover, platelets, after treatment with a crude preparation of CNP, which removes Gc, could be stimulated by BDB-IgG as well as or better than control platelets, but were unreactive with bovine vWF. We conclude that the Gc-moiety of GP Ib, which is involved in the bovine vWF binding site, is not the Fc-receptor on platelets. Thus, the inhibition, by human or rabbit IgG aggregates or monomeric rabbit IgG, of vWF-induced platelet agglutination, as reported by other authors, is either due to a steric effect resulting from a vicinal position of both receptors or involves the residual part of GP Ib after cleavage of Gc.

Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes

Bovine factor VIII/platelet aggregating factor was adsorbed into gold granules and the protein-gold complex added to either formalin-fixed or fresh washed human platelets. Following aggregation, binding of gold granules to the platelets was measured by monitoring the optical density of colloidal gold remaining in the supernatant. Scatchard analysis of binding data indicated that multiple classes of binding sites were present. The number of high affinity binding sites per formalin-fixed platelet depended on the concentration of ristocetin: 420 gold granules were calculated to bind at 1.4 mg/ml of ristocetin, 610 at 0.6 mg/ml of ristocetin and 875 when no ristocetin was added. Fresh washed platelets bound 1350 granules per cell in the absence of ristocetin. We conclude that during platelet aggregation, induced by bovine factor VIII, the binding sites on the platelet surface are only partially occupied.

Binding of colloidal gold granules, coated with bovine factor VIII, to human platelet membranes

Platelet aggregating factor (PAF) activity is preferentially associated with the larger molecular forms of bovine factor VIII and diminishes considerably after dissociation into smaller oligomers by mild disulphide reduction. PAF activity was regained by the binding of small factor VIII oligomers to colloidal gold granules with a mean diameter of 23 nm. In contrast, adsorption of large factor VIII polymers onto gold particles resulted in partial loss of PAF activity. Thus, an optimum multimeric size of bovine factor VIII appears to be required for the maximal expression of PAF activity. Gold granules, coated with reduced factor VIII, can be used as an electron-dense label. Their interaction with surface receptors for bovine factor VIII on either viable or formalin-fixed human platelets was demonstrated by transmission and scanning electron microscopy.

Proteolysis of human fixed, washed platelets by gram-negative bacterial metalloproteases: effect on von Willebrand factor-human platelet interactions

Fixed, washed platelets (FWP) are usually stable to aggregation with von Willebrand factor (vWF) from human and certain animal plasmas over several months of storage. When one lot of FWP lost its stability in less than 1 week, studies demonstrated contamination with Serratia marcescens. Extracellular proteases produced by S. marcescens, as well as by Pseudomonas aeruginosa and Escherichia coli, were found to cause loss of FWP aggregability. Purified proteases were prepared from cell-free culture filtrates of S. marcescens and two different strains of P. aeruginosa. They were used to study the effect on the interaction of FWP and vWF. All three purified proteases destroyed FWP aggregability in a time- and concentration-dependent fashion. The protease produced by S. marcescens (SP) was found to be at least eight times more potent against FWP as a substrate than either of the two P. aeruginosa enzymes. The ability of SP to destroy FWP aggregability was prevented by EDTA and could be restored by the addition of Zn2+ in slight molar excess. When compared with trypsin and chymotrypsin, SP was found to be highly selective in digesting the FWP membrane, even at concentrations greater than that established to give a similar loss of FWP aggregability. SP does not induce aggregation of fresh, washed platelets or PRP, but renders them unaggregable with vWF. These proteases may be useful research tools for studying membranes and vWF-platelet interactions.